Clinical and Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in New Zealand: Rapid Emergence of Sequence Type 5 (ST5)-SCCmec-IV as the Dominant Community-Associated MRSA Clone
Figure 1
Methicillin-resistant Staphylococcus aureus (MRSA) period-prevalence rates for clinical isolates in New Zealand, 2005–2011, stratified by (A) age, and (B) ethnicity.